'Treatment na ve' diaporamas de présentation

HCV : TRANSFORMING MANAGEMENT IN EGYPT

863 views • 72 slides

Antiretroviral Therapy & Tuberculosis

Antiretroviral Therapy & Tuberculosis. https://www.livescience.com/42937-photo-tuberculosis-bacteria.html. https:// kashpersky.com/human-immunodeficiency-virus. Ethel D. Weld, MD, Ph.D eweld@jhmi.edu. July 21, 2019 IAS Mexico City. Global burden of TB disease.

547 views • 53 slides

Best of HCV from EASL 2014

Best of HCV from EASL 2014. Geoffrey Dusheiko , MD London, UK. This activity is supported by an independent medical education grant from AbbVie , Bristol-Myers Squibb and Gilead Sciences. Abstract #O109.

676 views • 51 slides

2013 Antimicrobial Update Oklahoma ACP Chapter October 18, 2013

2013 Antimicrobial Update Oklahoma ACP Chapter October 18, 2013. Michelle R. Salvaggio MD FACP Associate Professor, Medicine Section of Infectious Diseases OUHSC. Outline. Clostridium difficile Methicillin resistant Staphylococcus aureus Hepatitis C HIV

602 views • 49 slides

HIV infection: conception, pregnancy and contraception

HIV infection: conception, pregnancy and contraception. Contents. Un/planned pregnancy. Contraception. Mother-to-child transmission (MTCT). Treatment and care during pregnancy. Post-exposure prophylaxis in infants. Co-morbility during pregnancy. Routine testing during pregnancy.

739 views • 42 slides

Lesson 1: Fundamentals of Hepatitis C Virus Treatment

Core Competency 4: HCV Treatment. Lesson 1: Fundamentals of Hepatitis C Virus Treatment. July 2017 Updated: December 2018. Lesson Objectives. At the end of this lesson, participants will be able to: Understand the goal of treatment Choose appropriate treatment settings

619 views • 29 slides

HCV cure: new treatment paradigms for HCV infection

543 views • 29 slides

437 views • 20 slides

Glecaprevir - Pibrentasvir in GT 1- 6 with Renal Disease EXPEDITION-4

266 views • 11 slides

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6 ASTRAL-1

196 views • 11 slides

WINR Study Flat versus Weight-Based Ribavirin Dosing

215 views • 11 slides

Ledipasvir-Sofosbuvir in GT1 or GT4 and HIV Coinfection ION-4

110 views • 10 slides

Ledipasvir-Sofosbuvir for 8 or 12 weeks in HCV GT1 ION-3

236 views • 9 slides

Sofosbuvir + Ribavirin in HCV Genotype 1 NIAID/NIH Trial

206 views • 9 slides

Ledipasvir-Sofosbuvir +/- 3 rd DAA in HCV Genotype 1 NIAID SYNERGY: Genotype 1

219 views • 8 slides

3D + RBV in Liver Transplant Recipients with Recurrent HCV GT1 Study M12-999

191 views • 8 slides

Ledipasvir-Sofosbuvir in GT-1 and HIV Coinfection ERADICATE Trial

223 views • 7 slides

Sofosbuvir + Ribavirin in HCV- HIV Coinfection: HCV GT 1,2,3,4 PHOTON-2 Trial

213 views • 7 slides

Sofosbuvir + Additional Agents ELECTRON (Overview): 6 parts, 22 arms

42 views • 4 slides

Temporal patterns in the rate of transmitted resistance in the UK

74 views • 1 slides